↓ Cooling
Business
GSK unveils 3-year cost-saving plan to fund late-stage R&D, move research HQ to AZ's backyard
GSK’s July 28 earnings beat powers a $2.5 billion three‑year savings drive and an Arizona HQ shift to fast‑track its drug pipeline.